1.Lewinsohn PM, Klein DN, Seeley JR. Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J Am Acad Child Adolesc Psychiatry. 1995; 34(4): 454–463.
2.Merikangas KR, He JP, Burstein M, etal. Lifetime prevalence of mental disorders in U.S. adolescents: results from the National Comorbidity Survey Replication—Adolescent Supplement (NCS-A). J Am Acad Child Adolesc Psychiatry. 2010; 49(10): 980–989.
3.Merikangas KR, Cui L, Kattan G, etal. Mania with and without depression in a community sample of US adolescents. Arch Gen Psychiatry. 2012; 69(9): 943–951.
4.Merikangas K, Lamers F. The “true” prevalence of bipolar II disorder. Curr Opin Psychiatry. 2011; 25(1): 19–23.
5.Faedda GL, Baldessarini RJ, Glovinsky IP, etal. Pediatric bipolar disorder: phenomenology and course of illness. Bipolar Disord. 2004; 6(4): 305–313.
6.Dilsaver SC, Benazzi F, Akiskal HS. Mixed states: the most common outpatient presentation of bipolar depressed adolescents? Psychopathology. 2005; 38(5): 268–272.
7.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text rev. Washington, DC: American Psychiatric Association; 2000.
8.Wozniak J, Spencer T, Biederman J, etal. The clinical characteristics of unipolar vs. bipolar major depression in ADHD youth. J Affect Disord. 2004; 82(Suppl 1): S59–S69.
9.Wagner KD, Findling RL, Emslie GJ, etal. Validation of the Mood Disorder Questionnaire for Bipolar Disorders in Adolescents. J Clin Psychiatry. 2006; 67: 827–830.
10.Youngstrom EA, Frazier TW, Findling RL, etal. Developing a ten item short form of the Parent General Behavior Inventory to assess for juvenile mania and hypomania. J Clin Psychiatry. 2008; 69: 831–839.
11.Pavuluri MN, Henry DB, Devineni B, etal. Child mania rating scale: development, reliability, and validity. J Am Acad Child Adolesc Psychiatry. 2006; 45: 550–560.
12.Wozniak J, Petty CR, Schreck M, etal. High level of persistence of pediatric bipolar-I disorder from childhood onto adolescent years: a four year prospective longitudinal follow-up study. J Psychiatr Res. 2011; 45(10): 1273–1282.
13.Jairam R, Srinath S, Girimaji SC, etal. A prospective 4–5 year follow-up of juvenile onset bipolar disorder. Bipolar Disord. 2004; 6(5): 386–394.
14.Birmaher B, Axelson D, Goldstein B, etal. Four-year longitudinal course of children and adolescents with bipolar spectrum disorders: the Course and Outcome of Bipolar Youth (COBY) study. Am J Psychiatry. 2009; 166(7): 795–804.
15.Geller B, Tillman R, Craney JL, etal. Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch Gen Psychiatry. 2004; 61(5): 459–467.
16.Geller B, Tillman R, Bolhofner K, etal. Child bipolar I disorder: prospective continuity with adult bipolar I disorder; characteristics of second and third episodes; predictors of 8-year outcome. Arch Gen Psychiatry. 2008; 65(10): 1125–1133.
17.DelBello MP, Chang K, Welge JA, etal. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder. Bipolar Disord. 2009; 11(5): 483–493.
18.Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006; 45(3): 298–304.
19.Biederman J, Joshi G, Mick E, etal. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther. 2010; 16(2): 91–102.
20.Soutullo CA, Díez-Suárez A, Figueroa-Quintana A. Adjunctive lamotrigine treatment for adolescents with bipolar disorder: retrospective report of five cases. J Child Adolesc Psychopharmacol. 2006; 16(3): 357–364.
21.Patel NC, DelBello MP, Bryan HS, etal. Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry. 2006; 45(3): 289–297.
22.Poznanski EO, Freman LN, Mokros HB. Children's Depression Rating Scale–Revised. Psychopharmacol Bull. 1985; 21: 979–989.
23.Spearing MK, Post RM, Leverich GS, etal. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 1997; 73(3): 159–171.
24.Biederman J, Mick E, Spencer TJ, etal. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol. 2000; 10(3): 185–192.
25.Desarkar P, Bakhla A, Sinha VK. Duloxetine-induced ultrarapid cycling in an adolescent with bipolar depression. J Clin Psychopharmacol. 2007; 27(1): 115–116.
26.Goldsmith M, Singh M, Chang K. Antidepressants and psychostimulants in pediatric populations: is there an association with mania? Pediatr Drugs. 2011; 13(4): 225–243.
27.Gracious BL, Chirieac MC, Costescu S, etal. Randomized, placebo-controlled trial of flax oil in pediatric bipolar disorder. Bipolar Disord. 2010; 12(2): 142–154.
28.Feeny NC, Danielson CK, Schwartz L, etal. Cognitive-behavioral therapy for bipolar disorders in adolescents: a pilot study. Bipolar Disord. 2006; 8(5): 508–515.
29.Goldstein TR, Axelson DA, Birmaher B, etal. Dialectical behavior therapy for adolescents with bipolar disorder: a 1-year open trial. J Am Acad Child Adolesc Psychiatry. 2007; 46(7): 820–830.
30.Fristad MA, Verducci JS, Walters K, etal. Impact of multifamily psychoeducational psychotherapy in treating children aged 8 to 12 years with mood disorders. Arch Gen Psychiatry. 2009; 66(9): 1013–1021.
31.Young RC, Biggs JT, Ziegler VE, etal. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry. 1978; 133: 429–435.